SCHEMBL39417

SCHEMBL39417

O=S(=O)(O)c1cc(O)c(O)cc1S(=O)(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPL P40238 5/20 0.42
NT5E P21589 2/20 0.42
HSD17B10 Q99714 3/20 0.41
LMNA P02545 2/20 0.41
HPGD P15428 1/20 0.41
HIF1A Q16665 1/20 0.41
ALDH1A1 P00352 2/20 0.39
TNNI3 P19429 1/20 0.39
TNNT2 P45379 1/20 0.39
TNNC1 P63316 1/20 0.39
HKDC1 Q2TB90 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CTRC Q99895 1/20 0.38
NQO1 P15559 1/20 0.37
ING2 Q9H160 1/20 0.37
NSD2 O96028 2/20 0.36
CASP6 P55212 2/20 0.36
DUSP3 P51452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30415382 1.00 MPL (0.42) MPLNT5EHSD17B10LMNAHPGD
SCHEMBL6236276 0.97 MPL (0.41) MPLNT5EHSD17B10LMNAHPGD
SCHEMBL5162847 0.97 MPL (0.41) MPLNT5EHSD17B10LMNAHPGD
SCHEMBL29520551 0.88 MPL (0.44) MPLNT5EHSD17B10LMNAHPGD
SCHEMBL668962 0.88 MPL (0.44) MPLNT5EHSD17B10LMNAHPGD
Persilic Acid SCHEMBL393079 0.88 HSD17B10 (0.45) MPLNT5EHSD17B10LMNAHPGD
SCHEMBL27566211 0.86 MPL (0.38) MPLNT5EHSD17B10LMNAHPGD
Persilic Acid SCHEMBL10587750 0.85 HSD17B10 (0.44) MPLNT5EHSD17B10LMNAHPGD
Persilic Acid SCHEMBL6930479 0.85 HSD17B10 (0.44) MPLNT5EHSD17B10LMNAHPGD
Persilic Acid SCHEMBL11553678 0.85 HSD17B10 (0.44) MPLNT5EHSD17B10LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 797 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1876227-B2 Detergent Compositions PROCTER & GAMBLE (US) 2020-08-12 EP claimed
CN-108550884-A A kind of flow battery 西南交通大学 2018-09-18 CN claimed
US-20120119420-A1 Nano metric composite ceramic component HOWMEDICA OSTEONICS CORP. 2012-05-17 US claimed
EP-1867707-B1 Detergent compositions PROCTER & GAMBLE (US) 2011-09-07 EP claimed
EP-1876227-B1 Detergent Compositions PROCTER & GAMBLE (US) 2011-03-23 EP claimed
US-20090105109-A1 Detergent compositions THE PROCTER & GAMBLE COMPANY 2009-04-23 US claimed
US-20080131717-A1 Protecting Wood With Stabilized Boron Complexes BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2008-06-05 US claimed
EP-1918264-A2 Method of synthesising a nano metric composite and for use thereof in a method for producing a ceramic component HOWMEDICA OSTEONICS CORP. (US) 2008-05-07 EP claimed
EP-1882731-A1 Detergent compositions The Procter and Gamble Company (US) 2008-01-30 EP claimed
WO-2008007320-A2 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2008-01-17 WO claimed
EP-1876227-A1 Detergent Compositions The Procter and Gamble Company (US) 2008-01-09 EP claimed
WO-2007144857-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2007-12-21 WO claimed
EP-1867707-A1 Detergent compositions The Procter and Gamble Company (US) 2007-12-19 EP claimed
EP-1529764-B1 Method of producing a ceramic component HOWMEDICA OSTEONICS CORP (US) 2006-11-02 EP claimed
US-20050167895-A1 Method of producing a ceramic component HOWMEDICA OSTEONICS CORP. (US) 2005-08-04 US claimed
EP-1529764-A1 Method of producing a ceramic component Howmedica Osteonics Corp. (US) 2005-05-11 EP claimed
US-20260139203-A1 FABRIC TREATMENT USING BACTERIAL SPORES THE PROCTER & GAMBLE CO (US) 2026-05-21 US disclosed
US-12624126-B2 Dextran-alpha-glucan graft copolymers and derivatives thereof Nutrition & Biosciences USA 4, Inc. (US) 2026-05-12 US disclosed
EP-0248506-A1 Metal ion labeling of carrier molecules Mallinckrodt, Inc. (a Delaware corporation) (US) 1987-12-09 EP disclosed
US-3957660-A SULFONATED PHENOLS AS DISPERSANTS TEXACO INC. (US) 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260139203-A1 FABRIC TREATMENT USING BACTERIAL SPORES SPOUT1, TYR, BAG2 MPL 1117/4885NT5E 4129/4885HSD17B10 3148/4885
US-20080131717-A1 Protecting Wood With Stabilized Boron Complexes BTD, BROX, BAP1 MPL 4881/4885NT5E 3174/4885HSD17B10 816/4885
US-12624126-B2 Dextran-alpha-glucan graft copolymers and derivatives thereof ALG8, DDOST, ALG1 MPL 1441/4885NT5E 3694/4885HSD17B10 4213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.